Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 2/20 | 0.70 |
| ▸ | LMNA | P02545 | 1/20 | 0.70 |
| ▸ | KCNK3 | O14649 | 3/20 | 0.53 |
| ▸ | KCNK9 | Q9NPC2 | 3/20 | 0.53 |
| ▸ | PTGS1 | P23219 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.51 |
| ▸ | F2R | P25116 | 1/20 | 0.50 |
| ▸ | PPIA | P62937 | 1/20 | 0.50 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | PTPRC | P08575 | 1/20 | 0.49 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.49 |
| ▸ | SCD | O00767 | 1/20 | 0.48 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.48 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1267035 | 1.00 | GAA (0.70) | GAALMNAKCNK3KCNK9PTGS1 | |
| SCHEMBL9830646 | 0.84 | GAA (0.75) | GAALMNAKCNK3KCNK9PTGS1 | |
| SCHEMBL9100658 | 0.84 | CTSS (0.58) | GAALMNAKCNK3KCNK9PTGS1 | |
| SCHEMBL8571125 | 0.84 | CTSS (0.58) | GAALMNAKCNK3KCNK9PTGS1 | |
| SCHEMBL8104116 | 0.82 | GAA (0.55) | GAALMNAPLK1PDK2 | |
| SCHEMBL3964208 | 0.82 | LMNA (0.72) | GAALMNAKCNK3KCNK9PTGS1 | |
| SCHEMBL2061662 | 0.82 | GAA (0.49) | GAALMNAKCNK3KCNK9PTGS1 | |
| SCHEMBL7984064 | 0.82 | CTSS (0.63) | GAALMNAPDK2 | |
| SCHEMBL15200725 | 0.81 | LMNA (0.66) | GAALMNAKCNK3KCNK9PTGS1 | |
| SCHEMBL27531979 | 0.81 | LMNA (0.66) | GAALMNAKCNK3KCNK9PTGS1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4612134-A1 | DIARYL DIAZOLE AND DIARYL TRIAZOLE DERIVATIVES FOR USE IN TREATING A DISEASE ASSOCIATED WITH KCNK13 ACTIVITY | Cerevance, Inc. (US) | 2025-09-10 | — | — | EP | disclosed |
| WO-2024095005-A1 | DIARYL DIAZOLE AND DIARYL TRIAZOLE DERIVATIVES FOR USE IN TREATING A DISEASE ASSOCIATED WITH KCNK13 ACTIVITY | Cerevance, Inc. (US) | 2024-05-10 | — | — | WO | disclosed |
| CN-117510470-A | Pyridazinone compounds and application thereof | 暨南大学 | 2024-02-06 | — | — | CN | disclosed |